USPTO serial 79183545
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $3,250
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thad Chaloemtiarana
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 South Wacker Drive, Suite 2900CHICAGO, IL 60606UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid analysis and testing apparatus; medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests | ACTIVE | — |
| 035 | Retail store services and online retail store services in connection with the sale of pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests; consulting services in the field of medical practice management for others in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases | ACTIVE | — |
| 042 | Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research, researching and developing new products in the fields of drugs, pharmaceuticals and medicines, and scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid | ACTIVE | — |
| 044 | Medical clinic services; health resort services in the nature of medical clinics; services for the provision of medical facilities; medical services; medical advisory services; medical diagnostic testing, monitoring and reporting services; providing medical information, consultancy and advisory services; medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for preventative care purposes; medical screening services in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases; medical services featuring health assessment surveys; consultancy and information services relating to all the aforesaid | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jan 22, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 8, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 8, 2023 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Nov 21, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 15, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 22, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 10, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 10, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 10, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 7, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 16, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 26, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 26, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 7, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 7, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 22, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 7, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2016 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 6, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 19, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 16, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |